查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519340

2024-2032 年按刺激类型、设备类型、应用、最终用户和地区分類的神经刺激设备市场报告

Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球神经刺激设备市场规模达87亿美元。人口老化的加剧、医疗保健支出的增加、非侵入性或微创神经刺激技术的发展以及政府和私人健康保险公司改进的报销政策是推动市场的一些主要因素。

神经刺激设备是先进的医疗技术，旨在调节和影响人体内的神经活动。这些设备透过向神经系统的特定区域传递电或磁脉衝来发挥作用，旨在缓解各种神经系统疾病和慢性疾病。它们提供了一种有前途的非侵入性或微创治疗方法，提高了患者的生活质量，并有可能为治疗各种神经系统疾病开闢新途径。神经刺激装置的两种主要类型是深部脑部刺激和脊髓刺激。 DBS 涉及将电极植入目标大脑区域，以调节异常神经讯号并治疗帕金森氏症、特发性震颤和肌张力失调等疾病。

日益增长的老龄化人口正在推动全球市场的发展。随着老年人口的增长，对治疗这些疾病的神经刺激设备的需求可能会增加。此外，非侵入性或微创神经刺激技术的发展扩大了潜在的患者群体，因为与传统外科手术相比，这些选择通常可以降低风险并缩短恢復时间。此外，一些地区政府和私人医疗保险公司改善了报销政策，使患者更容易获得神经刺激治疗，从而鼓励了市场成长。此外，正在进行的研究和临床试验为神经刺激装置的安全性和有效性提供了更多证据。这些研究的正面结果增强了医疗专业人员和患者对该技术的信心。此外，不断增长的医疗保健支出正在支持市场解决方案的成长，因为神经刺激设备为管理慢性病提供了一种经济有效的方法，这推动了它们的采用。

神经刺激设备市场趋势/驱动因素：

神经系统疾病的盛行率不断增加

帕金森氏症、癫痫、慢性疼痛和忧郁症等神经系统疾病影响着全世界数百万人，导致沉重的医疗负担。神经刺激装置为传统治疗难治或出现严重副作用的患者提供了一个有前景的解决方案。深部脑部刺激（DBS）在治疗帕金森氏症等运动障碍方面已显示出显着的功效，从而增加了对这些设备的需求。此外，慢性疼痛的发生率不断上升，特别是由于人口老化和久坐的生活方式，刺激了对脊髓刺激（SCS）设备的需求，以在不严重依赖药物的情况下缓解疼痛。随着政府和医疗机构优先考虑改善患者治疗效果并寻求创新解决方案，对神经刺激设备的需求预计将稳定成长。

神经刺激技术的不断进步

持续的研究和开发努力创造了更复杂、更有针对性的神经刺激设备。创新包括更小、更精确的电极、延长的电池寿命以及整合闭环系统，该系统可以根据患者的即时需求自动调整刺激参数。这些进步可提高治疗效果、减少副作用并提高患者舒适度。此外，植入神经刺激装置的微创手术的发展已将其适用性扩大到更广泛的患者群体，使治疗更容易获得，对患者和医疗保健提供者都更有吸引力。随着技术的不断发展，神经刺激设备可能会变得更有效率和更具适应性，从而进一步推动其采用和市场渗透。

对神经调节疗法的认识和接受度不断提高

随着越来越多的临床证据支持神经刺激装置在治疗各种神经系统疾病的有效性，医生也越来越多地向患者推荐这些疗法。此外，患者倡导团体和宣传活动在教育个人神经刺激的潜在益处方面发挥了至关重要的作用，从而提高了患者对这些治疗的接受度。透过神经刺激设备显着改善生活品质的患者的成功故事进一步促进了人们对这些疗法的正面看法。随着对神经调节的信任不断增长，对这些设备的需求预计会增加，从而推动市场扩张。此外，医疗保健组织、研究人员和设备製造商之间的合作，以传播意识并确保适当的使用，将有助于神经刺激设备市场的持续成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球神经刺激设备市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按刺激类型

  • 内部刺激
    • 市场走向
    • 市场预测
  • 外部刺激
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按设备类型

  • SCS（脊髓刺激）设备
    • 市场走向
    • 市场预测
  • DBS（深部脑部刺激）设备
    • 市场走向
    • 市场预测
  • SNS（荐神经刺激）设备
    • 市场走向
    • 市场预测
  • VNS（迷走神经刺激）设备
    • 市场走向
    • 市场预测
  • GES（胃电刺激）设备
    • 市场走向
    • 市场预测
  • 经皮神经电刺激装置
    • 市场走向
    • 市场预测
  • 经颅磁刺激装置
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 疼痛管理
    • 市场走向
    • 市场预测
  • 癫痫
    • 市场走向
    • 市场预测
  • 特发性震颤
    • 市场走向
    • 市场预测
  • 尿失禁和大便失禁
    • 市场走向
    • 市场预测
  • 沮丧
    • 市场走向
    • 市场预测
  • 肌张力失调
    • 市场走向
    • 市场预测
  • 帕金森氏症
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 復健中心
    • 市场走向
    • 市场预测
  • 医院
    • 市场走向
    • 市场预测
  • 医疗诊所
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

  • 概述
  • 入境物流
  • 营运
  • 出境物流
  • 行销与销售
  • 售后服务

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格指标

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Biocontrol Medical
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • Medtronic Inc.
    • Neuronetics Inc.
    • Neuropace Inc.
    • Neurosigma Inc.
    • Nevro Corporation
    • ST. Jude Medical Inc.
    • Synapse Biomedical Inc.
Product Code: SR112024A1892

The global neurostimulation devices market size reached US$ 8.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.6 Billion by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032. The growing aging population coupled with the rising healthcare expenditure, development of non-invasive or minimally invasive neurostimulation technologies, and improved reimbursement policies by government and private health insurers are some of the major factors propelling the market.

Neurostimulation devices are advanced medical technologies designed to modulate and influence neural activity within the human body. These devices work by delivering electrical or magnetic impulses to specific regions of the nervous system, aiming to alleviate various neurological conditions and chronic disorders. They offer a promising non-invasive or minimally invasive therapeutic approach, enhancing the quality of life for patients and potentially opening up new avenues for treating various neurological disorders. The two primary types of neurostimulation devices are deep brain stimulation and spinal cord stimulation. DBS involves implanting electrodes into targeted brain areas to regulate abnormal neural signals and treat conditions such as Parkinson's disease, essential tremor, and dystonia.

The growing aging population is driving the global market. As the elderly population grows, the demand for neurostimulation devices to manage these conditions is likely to rise. Moreover, the development of non-invasive or minimally invasive neurostimulation technologies has expanded the potential patient pool, as these options often offer reduced risks and quicker recovery times compared to traditional surgical procedures. Besides, improved reimbursement policies by government and private health insurers in some regions have made neurostimulation treatments more accessible to patients, encouraging market growth. Also, ongoing research and clinical trials have provided additional evidence for the safety and efficacy of neurostimulation devices. Positive results from these studies have increased confidence in the technology among medical professionals and patients. Furthermore, the rising healthcare expenditure is supporting the growth of market solutions as neurostimulation devices offer a cost-effective approach to managing chronic conditions, which has driven their adoption.

Neurostimulation Devices Market Trends/Drivers:

Increasing Prevalence of Neurological Disorders

Neurological conditions such as Parkinson's disease, epilepsy, chronic pain, and depression affect millions of people worldwide, leading to significant healthcare burdens. Neurostimulation devices offer a promising solution for patients who are refractory to conventional treatments or experience severe side effects. Deep brain stimulation (DBS) has demonstrated remarkable efficacy in managing movement disorders, such as Parkinson's disease, thereby augmenting the demand for these devices. Additionally, the escalating incidence of chronic pain, particularly due to aging populations and sedentary lifestyles, fuels the need for spinal cord stimulation (SCS) devices to provide pain relief without relying heavily on medications. As governments and healthcare organizations prioritize improved patient outcomes and seek innovative solutions, the demand for neurostimulation devices is expected to grow steadily.

Continual Advancements in Neurostimulation Technologies

Continuous research and development efforts have led to the creation of more sophisticated and targeted neurostimulation devices. Innovations include smaller and more precise electrodes, improved battery life, and the integration of closed-loop systems that can automatically adjust stimulation parameters based on real-time patient needs. These advancements translate to enhanced treatment outcomes, reduced side effects, and increased patient comfort. Moreover, the development of minimally invasive procedures for implanting neurostimulation devices has expanded their applicability to a broader patient population, making the treatments more accessible and appealing to both patients and healthcare providers. As technology continues to evolve, neurostimulation devices will likely become even more efficient and adaptable, further impelling their adoption and market penetration.

Growing Awareness and Acceptance of Neuromodulation Therapies

As more clinical evidence supports the effectiveness of neurostimulation devices in treating various neurological disorders, medical practitioners increasingly recommend these therapies to their patients. Additionally, patient advocacy groups and awareness campaigns have played a crucial role in educating individuals about the potential benefits of neurostimulation, leading to greater patient acceptance of these treatments. The success stories of patients who have experienced significant improvements in their quality of life through neurostimulation devices have further contributed to the positive perception of these therapies. As trust in neuromodulation grows, the demand for these devices is expected to increase, fuelling the market expansion. Furthermore, collaborations between healthcare organizations, researchers, and device manufacturers to spread awareness and ensure appropriate usage will contribute to the sustained growth of the neurostimulation devices market.

Neurostimulation Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global neurostimulation devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on stimulation type, device type, application, and end-user.

Breakup by Stimulation Type:

Internal Stimulation

External Stimulation

The report has provided a detailed breakup and analysis of the market based on the stimulation type. This includes internal stimulation and external stimulation.

Internal stimulation devices form a significant segment within the neurostimulation market, characterized by their implantable nature. These devices are surgically placed within the body to deliver targeted electrical or magnetic stimulation directly to specific neural structures. The demand for internal stimulation devices is driven by their efficacy in managing complex neurological disorders that do not respond adequately to medications or other treatments. The ability to precisely target neural circuits while providing reversible and adjustable stimulation parameters enhances treatment outcomes, leading to improved patient quality of life.

On the other hand, external stimulation devices represent another substantial segment in the neurostimulation market, characterized by their non-invasive or minimally invasive nature. These devices are applied externally to the body's surface, delivering stimulation without the need for surgical implantation.

Breakup by Device Type:

SCS (Spinal Cord Stimulation) Devices

DBS (Deep Brain Stimulation) Devices

SNS (Sacral Nerve Stimulation) Devices

VNS (Vagus Nerve Stimulation) Devices

GES (Gastric Electrical Stimulation) Devices

Transcutaneous Electrical Nerve Stimulation Devices

Transcranial Magnetic Stimulation Devices

Others

SCS (spinal cord stimulation) dominates the market

The report has provided a detailed breakup and analysis of the market based on the device type. This includes spinal cord stimulation (SCS) devices, deep brain stimulation (DBS) devices, sacral nerve stimulation (SNS) devices, vagus nerve stimulation (VNS) devices, gastric electrical stimulation (GES) devices, transcutaneous electrical nerve stimulation devices, transcranial magnetic stimulation devices, and other. According to the report, SCS (spinal cord stimulation) devices represented the largest segment.

SCS involves the implantation of electrodes along the spinal cord, where electrical impulses are delivered to modulate pain signals and provide relief for chronic pain conditions. The minimally invasive nature of the procedure offers numerous benefits, including shorter recovery times and reduced risks compared to invasive surgeries. Additionally, the customizable nature of SCS allows for individualized programming to target specific pain areas, tailoring treatment to meet each patient's unique needs. Moreover, continual advancements in SCS technology have led to more sophisticated devices with improved battery life, smaller implants, and enhanced programming capabilities, providing greater patient comfort and long-term sustainability. The focus on patient-centered care and shared decision-making has led to an increased emphasis on personalized pain management plans. Spinal cord stimulation, with its individualized programming capabilities, aligns well with this patient-centric approach, fueling its adoption in pain management strategies.

Breakup by Application:

Pain Management

Epilepsy

Essential Tremors

Urinary and Fecal Incontinence

Depression

Dystonia

Parkinson's Disease

Others

Pain management dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes pain management, epilepsy, essential tremors, urinary and fecal incontinence, depression, dystonia, Parkinson's disease, and others. According to the report, pain management represents the largest segment.

Neurostimulation devices designed for pain management offer a promising alternative, particularly spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). These technologies work by delivering controlled electrical impulses to target nerves, modulating pain signals, and thereby reducing the perception of pain. Pain management through neurostimulation has demonstrated remarkable efficacy in various chronic pain conditions, including neuropathic pain, failed back surgery syndrome (FBSS), and complex regional pain syndrome (CRPS). Additionally, the advancements in neurostimulation technology have led to more personalized and precise pain management solutions, allowing for tailored treatment strategies based on individual patient needs.

Breakup by End-User:

Rehabilitation Centers

Hospitals

Medical Clinics

Others

Hospitals dominates the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes rehabilitation centers, hospitals, medical clinics, and others. According to the report, hospitals represented the largest segment.

Hospitals play a central role in the diagnosis, treatment, and management of various neurological and chronic disorders, which often require neurostimulation therapies as part of the treatment plan. Hospitals have access to multidisciplinary teams of medical professionals, including neurologists, neurosurgeons, pain specialists, and anesthesiologists, who collaborate to provide comprehensive care to patients requiring neurostimulation therapies. Additionally, they are equipped with state-of-the-art operating rooms and facilities that meet stringent regulatory standards, ensuring safe and effective implantation procedures. Furthermore, neurostimulation devices often require careful programming and adjustments to optimize treatment outcomes, and hospitals have the resources to support these ongoing patient management needs.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest neurostimulation devices market share.

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Latin America (Brazil, Mexico, and Others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has a well-established healthcare infrastructure and is at the forefront of medical research and technological advancements. The presence of leading healthcare facilities, specialized neurology centers, and renowned research institutions fosters innovation and the adoption of cutting-edge neurostimulation technologies. Moreover, the region has a high prevalence of neurological disorders and chronic pain conditions, leading to a substantial demand for neurostimulation devices for effective management and treatment. The region's aging population, coupled with a growing awareness of neurostimulation therapies among patients and healthcare providers, further fuels market growth. Additionally, favorable reimbursement policies and regulatory frameworks in North America support the widespread adoption of neurostimulation devices.

Competitive Landscape:

Neurostimulation device manufacturers are heavily investing in research and development to enhance their existing products and develop new, innovative technologies. This involves conducting clinical trials, exploring new applications for neurostimulation, and improving the safety and efficacy of their devices. Moreover, companies are introducing new neurostimulation devices or release upgraded versions of existing ones. These launches aim to provide patients and healthcare professionals with state-of-the-art solutions that offer better outcomes and user experiences. Furthermore, companies actively seek to expand their market presence, both geographically and in terms of applications. They may pursue regulatory approvals in different regions, explore new therapeutic areas for neurostimulation, or target specific patient populations with unmet needs. Also, collaboration with other companies, research institutions, and healthcare organizations is common in the neurostimulation devices market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Biocontrol Medical

Boston Scientific Corporation

Cyberonics Inc.

Medtronic Inc.

Neuronetics Inc.

Neuropace Inc.

Neurosigma Inc.

Nevro Corporation

ST. Jude Medical Inc.

Synapse Biomedical Inc.

Recent Developments:

In April 2023, Synapse Biomedical Inc. received the approval for diaphragm pacing system, NeuRx DPS(R). The NeuRx DPS(R) is a battery-powered device that delivers electrical stimulation via four percutaneous intramuscular electrodes implanted into the diaphragm with minimally invasive laparoscopy. It is intended for use in patients with stable SCI with stimulatable diaphragms, but who lack control of their diaphragms. The device is indicated to allow patients 18 years and older to breathe without the assistance of a mechanical ventilator for at least four continuous hours a day.

In March 2023, Nevro Corporation announced the Launch of Revolutionary HFX iQ(TM) Spinal Cord Stimulation System to Personalize Treatment of Chronic Pain. It combines clinical inputs, such as pain relief and pain score, along with quality of life inputs, such as pain medication and activity level changes, to provide an individualized program setting for each patient.

In September 2022, Neuronetics Inc. launched Innovations to NeuroStar(R) Advanced Therapy's Proprietary TrakStar(R) Platform. The TrakStar upgrades include a simplified interface to quickly sort and prioritize potential patients with ease. It also streamlines the patient journey by bridging our proprietary PHQ-10 platform with our HIPAA-compliant TrakStar patient data management system making it easier to identify new patients and those needing re-treatment.

Key Questions Answered in This Report

  • 1. What was the size of the global neurostimulation devices market in 2023?
  • 2. What is the expected growth rate of the global neurostimulation devices market during 2024-2032?
  • 3. What are the key factors driving the global neurostimulation devices market?
  • 4. What has been the impact of COVID-19 on the global neurostimulation devices market?
  • 5. What is the breakup of the global neurostimulation devices market based on the device type?
  • 6. What is the breakup of the global neurostimulation devices market based on the application?
  • 7. What is the breakup of the global neurostimulation devices market based on the end-user?
  • 8. What are the key regions in the global neurostimulation devices market?
  • 9. Who are the key players/companies in the global neurostimulation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurostimulation Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Stimulation Type

  • 6.1 Internal Stimulation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 External Stimulation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 SCS (Spinal Cord Stimulation) Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 DBS (Deep Brain Stimulation) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 SNS (Sacral Nerve Stimulation) Devices
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 VNS (Vagus Nerve Stimulation) Devices
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 GES (Gastric Electrical Stimulation) Devices
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Transcutaneous Electrical Nerve Stimulation Devices
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Transcranial Magnetic Stimulation Devices
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Management
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Epilepsy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Essential Tremors
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Urinary and Fecal Incontinence
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Depression
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Dystonia
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Parkinson's Disease
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Rehabilitation Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Germany
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 France
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 United Kingdom
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Spain
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Russia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 China
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 South Korea
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Australia
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Indonesia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

  • 12.1 Overview
  • 12.2 Inbound Logistics
  • 12.3 Operations
  • 12.4 Outbound Logistics
  • 12.5 Marketing and Sales
  • 12.6 Post Sales Services

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Biocontrol Medical
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Boston Scientific Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Cyberonics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Medtronic Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Neuronetics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Neuropace Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Neurosigma Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Nevro Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 ST. Jude Medical Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Synapse Biomedical Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Neurostimulation Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurostimulation Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Neurostimulation Devices Market: Breakup by Stimulation Type (in %), 2023
  • Figure 4: Global: Neurostimulation Devices Market: Breakup by Device Type (in %), 2023
  • Figure 5: Global: Neurostimulation Devices Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Neurostimulation Devices Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Neurostimulation Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Neurostimulation Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Neurostimulation Devices (Internal Stimulation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Neurostimulation Devices (Internal Stimulation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Neurostimulation Devices (External Stimulation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Neurostimulation Devices (External Stimulation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Neurostimulation Devices (Other Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Neurostimulation Devices (Other Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Neurostimulation Devices (Pain Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Neurostimulation Devices (Pain Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Neurostimulation Devices (Epilepsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Neurostimulation Devices (Epilepsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Neurostimulation Devices (Essential Tremors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Neurostimulation Devices (Essential Tremors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Neurostimulation Devices (Depression) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Neurostimulation Devices (Depression) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Neurostimulation Devices (Dystonia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Neurostimulation Devices (Dystonia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Neurostimulation Devices (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Neurostimulation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Neurostimulation Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Neurostimulation Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Neurostimulation Devices (Rehabilitation Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Neurostimulation Devices (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Neurostimulation Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Neurostimulation Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Neurostimulation Devices (Medical Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Neurostimulation Devices (Medical Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Neurostimulation Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Neurostimulation Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: North America: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: United States: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: United States: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Canada: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Canada: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Asia Pacific: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Asia Pacific: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: China: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: China: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Japan: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Japan: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: India: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: India: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: South Korea: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: South Korea: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Australia: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Australia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Indonesia: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Indonesia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Latin America: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Latin America: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Brazil: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Brazil: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Mexico: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Mexico: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Middle East and Africa: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Middle East and Africa: Neurostimulation Devices Market: Breakup by Country (in %), 2023
  • Figure 101: Middle East and Africa: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Global: Neurostimulation Devices Industry: SWOT Analysis
  • Figure 103: Global: Neurostimulation Devices Industry: Value Chain Analysis
  • Figure 104: Global: Neurostimulation Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurostimulation Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Neurostimulation Devices Market Forecast: Breakup by Stimulation Type (in Million US$), 2024-2032
  • Table 3: Global: Neurostimulation Devices Market Forecast: Breakup by Device Type (in Million US$), 2024-2032
  • Table 4: Global: Neurostimulation Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Neurostimulation Devices Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Neurostimulation Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Neurostimulation Devices Market: Competitive Structure
  • Table 8: Global: Neurostimulation Devices Market: Key Players